|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
decreases response to substance multiple interactions |
EXP ISO |
ABCB1 protein results in decreased susceptibility to Dactinomycin Dactinomycin inhibits the reaction [[Particulate Matter results in increased expression of and results in increased activity of ABCB1 protein] which results in increased uptake of (N-5-(4-nitrobenzofurazan-7-yl)lysyl(8))cyclosporine]; Dactinomycin inhibits the reaction [[Vehicle Emissions results in increased expression of and results in increased activity of ABCB1 protein] which results in increased uptake of (N-5-(4-nitrobenzofurazan-7-yl)lysyl(8))cyclosporine]; Dactinomycin inhibits the reaction [coptisine results in increased expression of ABCB1A mRNA]; Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of and results in increased activity of ABCB1 protein]; Dactinomycin inhibits the reaction [tetrabromobisphenol A results in increased expression of and results in increased activity of ABCB1A protein]; Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of and results in increased activity of ABCB1 protein] Dactinomycin inhibits the reaction [Estradiol results in increased expression of ABCB1 mRNA]; Dactinomycin inhibits the reaction [Estradiol results in increased expression of ABCB1 protein]; Dactinomycin inhibits the reaction [Progesterone results in increased expression of ABCB1 mRNA]; Dactinomycin inhibits the reaction [Progesterone results in increased expression of ABCB1 protein]; Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of ABCB1 mRNA] |
CTD |
PMID:1967174 PMID:11455017 PMID:15725475 PMID:18474546 PMID:19813763 PMID:20410605 PMID:30830211 More...
|
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
decreases response to substance |
EXP ISO |
ABCC1 protein results in decreased susceptibility to Dactinomycin |
CTD |
PMID:11455017 PMID:12067707 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
decreases response to substance multiple interactions |
ISO EXP |
ABCC2 protein results in decreased susceptibility to Dactinomycin Dactinomycin inhibits the reaction [Bucladesine results in increased expression of ABCC2 mRNA] Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of ABCC2 mRNA] |
CTD |
PMID:11408547 PMID:11455017 PMID:26049102 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 (JR blood group) |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Daunorubicin results in increased expression of ABCG2 mRNA]; Dactinomycin inhibits the reaction [Doxorubicin results in increased expression of ABCG2 mRNA]; Dactinomycin inhibits the reaction [Mitoxantrone results in increased expression of ABCG2 mRNA]; Dactinomycin inhibits the reaction [SHH protein alternative form results in increased expression of ABCG2 protein]; Dactinomycin inhibits the reaction [Sulfasalazine results in increased expression of ABCG2 mRNA] |
CTD |
PMID:20019844 PMID:21625222 |
|
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
|
|
G |
ABHD3 |
abhydrolase domain containing 3, phospholipase |
increases expression |
EXP |
Dactinomycin results in increased expression of ABHD3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr18:21,650,901...21,704,774
Ensembl chr18:21,650,901...21,704,780
|
|
G |
ACE |
angiotensin I converting enzyme |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Aldosterone results in increased activity of ACE protein]; Dactinomycin inhibits the reaction [Aldosterone results in increased expression of ACE mRNA] |
CTD |
PMID:15932931 |
|
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
ACSL6 |
acyl-CoA synthetase long chain family member 6 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased expression of ACSL6 mRNA] |
CTD |
PMID:10585473 |
|
NCBI chr 5:131,949,973...132,012,213
Ensembl chr 5:131,949,973...132,012,243
|
|
G |
ADAM9 |
ADAM metallopeptidase domain 9 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] |
CTD |
PMID:17018608 |
|
NCBI chr 8:38,996,973...39,105,261
Ensembl chr 8:38,996,754...39,105,445
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Cycloheximide results in increased expression of ADRB2 protein]; Dactinomycin inhibits the reaction [EDN1 protein results in increased expression of ADRB2 mRNA]; Dactinomycin inhibits the reaction [Formoterol Fumarate affects the expression of ADRB2 mRNA] |
CTD |
PMID:22483689 PMID:24705868 |
|
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
AGRP |
agouti related neuropeptide |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [bisphenol A results in increased expression of AGRP mRNA] Dactinomycin results in decreased expression of AGRP mRNA |
CTD |
PMID:32575098 |
|
NCBI chr16:67,482,571...67,483,547
Ensembl chr16:67,482,571...67,483,547
|
|
G |
AGT |
angiotensinogen |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA]; Dactinomycin inhibits the reaction [Amiodarone results in increased expression of AGT mRNA] Dactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA]; Dactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA]; Dactinomycin promotes the reaction [Spironolactone inhibits the reaction [AGT protein results in increased expression of CTF1 mRNA]]; Dactinomycin promotes the reaction [Valsartan inhibits the reaction [AGT protein results in increased expression of CTF1 mRNA]] |
CTD |
PMID:16705055 PMID:17214612 PMID:19292980 PMID:23288202 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [TGFB1 protein results in decreased expression of AHR mRNA] ARNT protein promotes the reaction [Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased degradation of AHR protein]]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of AHR protein]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased degradation of AHR protein] |
CTD |
PMID:9145908 PMID:16226227 PMID:25637755 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AICDA |
activation induced cytidine deaminase |
multiple interactions |
ISO |
[Dactinomycin co-treated with Alpha-Amanitin] inhibits the reaction [Estradiol results in increased expression of AICDA mRNA] |
CTD |
PMID:19139166 |
|
NCBI chr12:8,602,170...8,612,859
Ensembl chr12:8,602,155...8,613,242
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
multiple interactions |
EXP |
[Dactinomycin co-treated with TNFSF10 protein] results in increased expression of AIFM1 protein |
CTD |
PMID:17707539 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases stability |
ISO EXP |
PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] Dactinomycin results in decreased stability of AKT1 mRNA PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein]; YTHDF1 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]; YTHDF1 protein affects the reaction [YTHDF2 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]]; YTHDF2 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]; YTHDF2 protein affects the reaction [YTHDF1 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]] |
CTD |
PMID:14640974 PMID:37061066 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
ALPI |
alkaline phosphatase, intestinal |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Fish Oils results in increased activity of ALPI protein] |
CTD |
PMID:15599000 |
|
NCBI chr 2:232,456,153...232,460,753
Ensembl chr 2:232,456,125...232,460,753
|
|
G |
ALX3 |
ALX homeobox 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Folic Acid results in increased expression of ALX3 mRNA] |
CTD |
PMID:20534379 |
|
NCBI chr 1:110,059,870...110,070,672
Ensembl chr 1:110,059,870...110,070,672
|
|
G |
AOC1 |
amine oxidase copper containing 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Epinephrine results in increased activity of AOC1 protein]; Dactinomycin inhibits the reaction [Isoproterenol results in increased activity of AOC1 protein]; Dactinomycin inhibits the reaction [Terbutaline results in increased activity of AOC1 protein] |
CTD |
PMID:2860926 PMID:6218830 |
|
NCBI chr 7:150,852,120...150,861,504
Ensembl chr 7:150,824,627...150,861,504
|
|
G |
AQP1 |
aquaporin 1 (Colton blood group) |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [cobaltous chloride results in increased expression of AQP1 mRNA] |
CTD |
PMID:22415096 |
|
NCBI chr 7:30,911,853...30,925,516
Ensembl chr 7:30,911,853...30,925,517
|
|
G |
ARHGDIB |
Rho GDP dissociation inhibitor beta |
increases expression |
EXP |
Dactinomycin results in increased expression of ARHGDIB mRNA |
CTD |
PMID:21527772 |
|
NCBI chr12:14,942,015...14,961,601
Ensembl chr12:14,942,031...14,961,728
|
|
G |
ARNT |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
ARNT protein promotes the reaction [Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased degradation of AHR protein]] |
CTD |
PMID:16226227 |
|
NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
|
|
G |
ATF4 |
activating transcription factor 4 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Bortezomib results in increased expression of ATF4 mRNA]; Dactinomycin inhibits the reaction [Bortezomib results in increased expression of ATF4 protein]; Dactinomycin inhibits the reaction [Fenretinide results in increased expression of ATF4 mRNA]; Dactinomycin inhibits the reaction [Fenretinide results in increased expression of ATF4 protein]; Dactinomycin inhibits the reaction [Thapsigargin results in increased expression of ATF4 mRNA]; Dactinomycin inhibits the reaction [Thapsigargin results in increased expression of ATF4 protein] |
CTD |
PMID:20022965 |
|
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
|
|
G |
ATG7 |
autophagy related 7 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Ethanol results in increased expression of ATG7 protein] |
CTD |
PMID:24095927 |
|
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
|
|
G |
ATM |
ATM serine/threonine kinase |
multiple interactions |
EXP |
Dactinomycin results in decreased expression of and results in increased phosphorylation of ATM protein |
CTD |
PMID:31226288 |
|
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,823...108,369,102
|
|
G |
AVP |
arginine vasopressin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [[Phenylephrine co-treated with Adenosine Triphosphate] results in increased secretion of AVP protein] |
CTD |
PMID:11102496 |
|
NCBI chr20:3,082,556...3,084,724
Ensembl chr20:3,082,556...3,084,724
|
|
G |
AXL |
AXL receptor tyrosine kinase |
increases expression |
EXP |
Dactinomycin results in increased expression of AXL mRNA |
CTD |
PMID:21527772 |
|
NCBI chr19:41,219,223...41,261,766
Ensembl chr19:41,219,223...41,261,766
|
|
G |
BAG3 |
BAG cochaperone 3 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Lipopolysaccharides results in increased expression of BAG3 mRNA] |
CTD |
PMID:22020323 |
|
NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,380...119,677,819
|
|
G |
BAK1 |
BCL2 antagonist/killer 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA] Dactinomycin promotes the reaction [BAK1 protein binds to BAK1 protein] |
CTD |
PMID:21281706 PMID:26670606 |
|
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP ISO |
Dactinomycin results in increased expression of BAX mRNA; Dactinomycin results in increased expression of BAX protein Dactinomycin promotes the reaction [BAX protein binds to BAX protein] Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAX mRNA] Morphine inhibits the reaction [Dactinomycin results in increased expression of BAX protein]; Naloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in increased expression of BAX protein]] |
CTD |
PMID:10760829 PMID:12927789 PMID:21281706 PMID:21527772 PMID:26670606 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BBC3 |
BCL2 binding component 3 |
increases expression |
EXP |
Dactinomycin results in increased expression of BBC3 mRNA; Dactinomycin results in increased expression of BBC3 protein |
CTD |
PMID:17581298 |
|
NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases expression |
EXP |
BCL2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 protein]; Dactinomycin inhibits the reaction [IL1B results in increased expression of BCL2 protein]; Dactinomycin inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]; Dactinomycin inhibits the reaction [TNF results in increased expression of BCL2 protein]; Morphine inhibits the reaction [Dactinomycin results in decreased expression of BCL2 protein]; Naloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in decreased expression of BCL2 protein]] Dactinomycin results in decreased expression of BCL2 mRNA; Dactinomycin results in decreased expression of BCL2 protein |
CTD |
PMID:11726273 PMID:11880364 PMID:12927789 PMID:16492401 PMID:17581298 PMID:34303041 More...
|
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2A1 |
BCL2 related protein A1 |
multiple interactions |
EXP |
BCL2A1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196
|
|
G |
BCL2L1 |
BCL2 like 1 |
decreases expression multiple interactions increases expression |
EXP |
Dactinomycin results in decreased expression of BCL2L1 protein Dexamethasone inhibits the reaction [Dactinomycin results in increased expression of BCL2L1 protein] Dactinomycin results in increased expression of BCL2L1 protein; Dactinomycin results in increased expression of BCL2L1 protein alternative form |
CTD |
PMID:9326359 PMID:12430140 PMID:15592511 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BCL2L11 |
BCL2 like 11 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 mRNA] |
CTD |
PMID:16166651 |
|
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
|
|
G |
BDNF |
brain derived neurotrophic factor |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 analog results in increased expression of BDNF mRNA]; Dactinomycin inhibits the reaction [NEPP11 compound results in increased expression of BDNF mRNA] Dactinomycin results in decreased expression of BDNF mRNA |
CTD |
PMID:22982731 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
G |
BECN1 |
beclin 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Ethanol results in increased expression of BECN1 protein] |
CTD |
PMID:24095927 |
|
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
|
|
G |
BID |
BH3 interacting domain death agonist |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [vorinostat results in increased cleavage of BID protein] Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of BID mRNA] |
CTD |
PMID:11535817 PMID:16166651 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
BIRC3 |
baculoviral IAP repeat containing 3 |
multiple interactions |
EXP |
BIRC3 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
|
|
G |
BNIP3 |
BCL2 interacting protein 3 |
multiple interactions |
ISO |
[Dactinomycin co-treated with TNF protein] results in increased expression of BNIP3 mRNA; Dactinomycin inhibits the reaction [Ethanol results in increased expression of BNIP3 protein]; Dactinomycin inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] |
CTD |
PMID:11592958 PMID:19442826 PMID:24095927 |
|
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
|
|
G |
BSDC1 |
BSD domain containing 1 |
increases expression |
EXP |
Dactinomycin results in increased expression of BSDC1 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:32,364,633...32,394,441
Ensembl chr 1:32,364,633...32,394,731
|
|
G |
BTRC |
beta-transducin repeat containing E3 ubiquitin protein ligase |
multiple interactions |
EXP |
Dactinomycin promotes the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC mRNA]; Dactinomycin promotes the reaction [[WEHI-539 co-treated with venetoclax] results in decreased expression of BTRC mRNA] |
CTD |
PMID:35561756 |
|
NCBI chr10:101,354,048...101,557,313
Ensembl chr10:101,354,033...101,557,321
|
|
G |
C1QBP |
complement C1q binding protein |
decreases response to substance |
EXP |
C1QBP protein results in decreased susceptibility to Dactinomycin |
CTD |
PMID:25354864 |
|
NCBI chr17:5,432,777...5,439,155
Ensembl chr17:5,432,777...5,448,830
|
|
G |
CACNA1G |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA] |
CTD |
PMID:19292980 |
|
NCBI chr17:50,560,715...50,627,474
Ensembl chr17:50,560,715...50,627,474
|
|
G |
CACNA1H |
calcium voltage-gated channel subunit alpha1 H |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA] |
CTD |
PMID:19292980 |
|
NCBI chr16:1,153,106...1,221,768
Ensembl chr16:1,153,103...1,224,169
|
|
G |
CASP2 |
caspase 2 |
increases cleavage |
EXP |
Dactinomycin results in increased cleavage of CASP2 protein |
CTD |
PMID:10663630 |
|
NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity decreases expression |
EXP ISO |
[TNF co-treated with Dactinomycin] results in increased activity of CASP3 protein; [TNF protein co-treated with Dactinomycin] results in increased activity of CASP3 protein; Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Dactinomycin inhibits the reaction [Biological Products results in increased expression of CASP3 mRNA]; Dactinomycin promotes the reaction [TNF results in increased activity of CASP3 protein] Dactinomycin results in increased cleavage of and results in increased activity of CASP3 protein [Dactinomycin co-treated with TNF protein] results in increased activity of CASP3 protein Dactinomycin results in increased activity of CASP3 protein Dactinomycin results in decreased expression of CASP3 mRNA |
CTD |
PMID:10663630 PMID:16001973 PMID:16492401 PMID:21496118 PMID:22654482 PMID:23300732 PMID:26670606 PMID:34303041 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP7 |
caspase 7 |
multiple interactions decreases expression |
EXP |
[Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP7 protein; [TNF co-treated with Dactinomycin] results in increased activity of CASP7 protein; [TNF protein co-treated with Dactinomycin] results in increased activity of CASP7 protein; Dactinomycin promotes the reaction [TNF results in increased activity of CASP7 protein] Dactinomycin results in decreased expression of CASP7 mRNA |
CTD |
PMID:16001973 PMID:16492401 PMID:17707539 PMID:21496118 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
decreases expression |
EXP |
Dactinomycin results in decreased expression of CASP8 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases cleavage |
EXP ISO |
[Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP9 protein Dactinomycin results in increased cleavage of CASP9 protein |
CTD |
PMID:17707539 PMID:26670606 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAV1 |
caveolin 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] |
CTD |
PMID:15314095 |
|
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL11 mRNA] |
CTD |
PMID:15531761 |
|
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] |
CTD |
PMID:15531761 PMID:16705055 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCN4 |
cellular communication network factor 4 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CCN4 mRNA] |
CTD |
PMID:19238344 |
|
NCBI chr 8:133,191,039...133,231,690
Ensembl chr 8:133,191,039...133,231,690
|
|
G |
CCNA2 |
cyclin A2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Homocysteine results in increased expression of CCNA2 mRNA] |
CTD |
PMID:8550827 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCND1 |
cyclin D1 |
decreases stability |
ISO |
Dactinomycin results in decreased stability of CCND1 mRNA |
CTD |
PMID:15610522 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CD1D |
CD1d molecule |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of CD1D mRNA] |
CTD |
PMID:17392484 |
|
NCBI chr 1:158,178,030...158,186,427
Ensembl chr 1:158,178,030...158,186,427
|
|
G |
CD28 |
CD28 molecule |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD28 protein] |
CTD |
PMID:11465111 |
|
NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,475...203,738,912
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
multiple interactions decreases expression |
EXP |
2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone inhibits the reaction [Dactinomycin results in increased expression of and affects the localization of CDKN1A protein]; Dactinomycin results in increased expression of and affects the localization of CDKN1A protein Dactinomycin results in decreased expression of CDKN1A protein |
CTD |
PMID:12807743 PMID:14601052 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
multiple interactions |
ISO |
CDKN1B protein affects the reaction [Dactinomycin results in increased degradation of PTGS2 mRNA] |
CTD |
PMID:23639288 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CEBPB |
CCAAT enhancer binding protein beta |
decreases expression |
EXP |
Dactinomycin results in decreased expression of CEBPB mRNA |
CTD |
PMID:16001973 |
|
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
|
|
G |
CEL |
carboxyl ester lipase |
increases expression |
EXP |
Dactinomycin results in increased expression of CEL mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 9:133,061,981...133,071,861
Ensembl chr 9:133,061,981...133,071,861
|
|
G |
CFLAR |
CASP8 and FADD like apoptosis regulator |
decreases expression |
EXP |
Dactinomycin results in decreased expression of CFLAR protein |
CTD |
PMID:11234897 PMID:14601052 |
|
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
|
|
G |
CKB |
creatine kinase B |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Estradiol results in increased expression of CKB protein]; Dactinomycin inhibits the reaction [Methoxychlor results in increased expression of CKB protein] |
CTD |
PMID:7839363 |
|
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
|
|
G |
CLMN |
calmin |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of CLMN mRNA] |
CTD |
PMID:16688769 |
|
NCBI chr14:95,181,940...95,319,908
Ensembl chr14:95,181,940...95,319,908
|
|
G |
CNMD |
chondromodulin |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [hydroquinone results in increased expression of CNMD protein] |
CTD |
PMID:19525446 |
|
NCBI chr13:52,703,264...52,739,820
Ensembl chr13:52,703,264...52,739,820
|
|
G |
CNR1 |
cannabinoid receptor 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Gemcitabine results in increased expression of CNR1 mRNA] |
CTD |
PMID:21525939 |
|
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
|
|
G |
CNR2 |
cannabinoid receptor 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Gemcitabine results in increased expression of CNR2 mRNA] |
CTD |
PMID:21525939 |
|
NCBI chr 1:23,870,515...23,913,362
Ensembl chr 1:23,870,515...23,913,362
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions decreases expression |
EXP |
Dactinomycin inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mRNA] Dactinomycin results in decreased expression of COL1A1 mRNA |
CTD |
PMID:11216681 PMID:18253093 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL1A2 |
collagen type I alpha 2 chain |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [LEP protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:12704794 |
|
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
CRABP2 |
cellular retinoic acid binding protein 2 |
increases expression |
EXP |
Dactinomycin results in increased expression of CRABP2 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:156,699,606...156,705,784
Ensembl chr 1:156,699,606...156,705,816
|
|
G |
CS |
citrate synthase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Hydrocortisone results in decreased activity of CS protein] |
CTD |
PMID:6476976 |
|
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [Reactive Oxygen Species results in increased expression of CSF2 protein] Dactinomycin inhibits the reaction [IL1B results in increased secretion of CSF2 protein]; Dactinomycin inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein]; Dactinomycin inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] |
CTD |
PMID:9606035 PMID:10645887 PMID:11752025 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CTF1 |
cardiotrophin 1 |
multiple interactions |
ISO |
Dactinomycin promotes the reaction [Spironolactone inhibits the reaction [AGT protein results in increased expression of CTF1 mRNA]]; Dactinomycin promotes the reaction [Valsartan inhibits the reaction [AGT protein results in increased expression of CTF1 mRNA]] |
CTD |
PMID:23288202 |
|
NCBI chr16:30,895,846...30,903,560
Ensembl chr16:30,896,614...30,903,547
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions increases expression |
EXP |
[Dactinomycin co-treated with lipopolysaccharide, E. coli O26-B6] results in decreased expression of CXCL8 mRNA; Dactinomycin inhibits the reaction [arsenic trioxide promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL8 mRNA]]; Dactinomycin inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; Dactinomycin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL8 mRNA]; Dactinomycin inhibits the reaction [sphingosine 1-phosphate results in increased expression of CXCL8 mRNA]; Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [Zinc deficiency results in decreased expression of CXCL8 protein]]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; Dactinomycin inhibits the reaction [Zinc Oxide results in increased expression of CXCL8 mRNA]; Dactinomycin inhibits the reaction [Zinc Oxide results in increased expression of CXCL8 protein]; Dactinomycin promotes the reaction [3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8]] Dactinomycin results in increased expression of CXCL8 mRNA |
CTD |
PMID:12039947 PMID:12812920 PMID:15531761 PMID:18281166 PMID:18308354 PMID:20194077 PMID:21777978 PMID:29594315 More...
|
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYCS |
cytochrome c, somatic |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CYCS mRNA] |
CTD |
PMID:21281706 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYGB |
cytoglobin |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of CYGB mRNA] |
CTD |
PMID:25781201 |
|
NCBI chr17:76,527,356...76,551,193
Ensembl chr17:76,527,356...76,551,175
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions decreases expression |
ISO EXP |
Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [chromium trioxide results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Copper results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Lead results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Mercury results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [SB 203580 results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [tetrandrine results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [tetrandrine results in increased expression of CYP1A1 protein]; Dactinomycin promotes the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; Dactinomycin promotes the reaction [Cycloheximide results in increased expression of CYP1A1 mRNA] Dactinomycin results in decreased expression of CYP1A1 mRNA Dactinomycin inhibits the reaction [afimoxifene results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [cryptotanshinone results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [dihydrotanshinone I results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [harman results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Itraconazole results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Ketoconazole results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [NSC 674495 results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [Sunitinib results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [T-2 Toxin results in increased expression of CYP1A1 mRNA]; Dactinomycin inhibits the reaction [tanshinone results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:1934297 PMID:10359656 PMID:11577022 PMID:11752201 PMID:16093525 PMID:17283379 PMID:17606337 PMID:19901195 PMID:20187624 PMID:20732341 PMID:21262253 PMID:21732638 PMID:23288144 PMID:26318284 PMID:26640276 PMID:31470059 More...
|
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA]; Dactinomycin inhibits the reaction [dihydrotanshinone I results in increased expression of CYP1A2 mRNA]; Dactinomycin inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA] |
CTD |
PMID:21262253 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
multiple interactions decreases expression |
EXP ISO |
Dactinomycin inhibits the reaction [NSC 674495 results in increased expression of CYP1B1 mRNA] Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of CYP1B1 protein] Dactinomycin results in decreased expression of CYP1B1 mRNA Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:11577022 PMID:11752201 PMID:21867498 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
increases stability multiple interactions |
ISO |
Dactinomycin results in increased stability of CYP2A5 mRNA Dactinomycin affects the reaction [HNRNPA1 protein binds to CYP2A5 mRNA]; Dactinomycin inhibits the reaction [Cyclic AMP results in increased expression of CYP2A5 mRNA]; Dactinomycin inhibits the reaction [Phenobarbital results in increased expression of CYP2A5 mRNA] |
CTD |
PMID:12754101 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA] |
CTD |
PMID:9007836 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP2F1 |
cytochrome P450 family 2 subfamily F member 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] |
CTD |
PMID:20187624 |
|
NCBI chr19:41,114,432...41,128,381
Ensembl chr19:41,114,432...41,128,381
|
|
G |
CYP2S1 |
cytochrome P450 family 2 subfamily S member 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA] |
CTD |
PMID:17277313 |
|
NCBI chr19:41,193,219...41,207,539
Ensembl chr19:41,193,210...41,207,539
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [o,p'-DDT results in increased expression of CYP3A4 mRNA]; Dactinomycin inhibits the reaction [U 0126 results in increased expression of CYP3A4 mRNA] Dactinomycin inhibits the reaction [Methylcholanthrene results in increased expression of CYP3A2 mRNA]; Dactinomycin inhibits the reaction [Phenobarbital results in increased expression of CYP3A2 mRNA]; Dactinomycin inhibits the reaction [pyridine results in increased expression of CYP3A2 mRNA] |
CTD |
PMID:11181506 PMID:15795092 PMID:24819614 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
CYP3A5 |
cytochrome P450 family 3 subfamily A member 5 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [U 0126 results in increased expression of CYP3A5 mRNA] |
CTD |
PMID:24819614 |
|
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
|
|
G |
CYP3A7 |
cytochrome P450 family 3 subfamily A member 7 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [U 0126 results in increased expression of CYP3A7 mRNA] |
CTD |
PMID:24819614 |
|
NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
|
|
G |
DDAH2 |
DDAH family member 2, ADMA-independent |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Nebivolol results in increased expression of DDAH2 mRNA] |
CTD |
PMID:17977009 |
|
NCBI chr 6:31,727,040...31,730,263
Ensembl chr 6:31,727,038...31,730,617
|
|
G |
DIO3 |
iodothyronine deiodinase 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Hydrogen Peroxide results in increased activity of DIO3 protein] |
CTD |
PMID:18420745 |
|
NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452
|
|
G |
DPYSL4 |
dihydropyrimidinase like 4 |
increases expression |
EXP |
Dactinomycin results in increased expression of DPYSL4 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr10:132,186,948...132,205,759
Ensembl chr10:132,186,948...132,205,759
|
|
G |
EDN1 |
endothelin 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [EDN1 protein results in increased expression of ADRB2 mRNA] |
CTD |
PMID:22483689 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EDNRA |
endothelin receptor type A |
multiple interactions |
ISO |
[Dimethyl Sulfoxide co-treated with Dactinomycin] results in decreased expression of EDNRA mRNA; [Dimethyl Sulfoxide co-treated with Dactinomycin] results in decreased expression of EDNRA protein; Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of EDNRA mRNA]; Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of EDNRA protein] |
CTD |
PMID:20561571 |
|
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
|
|
G |
EDNRB |
endothelin receptor type B |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Cyclosporine results in increased expression of EDNRB mRNA]; Dactinomycin inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB mRNA]; Dactinomycin inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB protein]; Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of EDNRB mRNA]; Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of EDNRB protein]; Dactinomycin inhibits the reaction [Smoke analog results in increased expression of EDNRB protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of EDNRB mRNA] |
CTD |
PMID:20561571 PMID:20716444 PMID:22207076 PMID:25772258 |
|
NCBI chr13:77,895,481...77,975,527
Ensembl chr13:77,895,481...77,975,529
|
|
G |
EFNB2 |
ephrin B2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of EFNB2 mRNA] |
CTD |
PMID:16688769 |
|
NCBI chr13:106,489,745...106,535,662
Ensembl chr13:106,489,745...106,535,662
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA] |
CTD |
PMID:12632255 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Estradiol results in increased expression of EGFR protein]; Dactinomycin inhibits the reaction [Methoxychlor results in increased expression of EGFR protein] |
CTD |
PMID:8888411 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGR1 |
early growth response 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA] |
CTD |
PMID:1717835 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
ELOVL3 |
ELOVL fatty acid elongase 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Norepinephrine results in increased expression of ELOVL3 mRNA]; Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of ELOVL3 mRNA] |
CTD |
PMID:17726147 |
|
NCBI chr10:102,224,767...102,229,589
Ensembl chr10:102,226,299...102,229,589
|
|
G |
EMP1 |
epithelial membrane protein 1 |
increases expression |
EXP |
Dactinomycin results in increased expression of EMP1 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr12:13,196,726...13,219,941
Ensembl chr12:13,196,723...13,219,941
|
|
G |
EMP3 |
epithelial membrane protein 3 (MAM blood group) |
increases expression |
EXP |
Dactinomycin results in increased expression of EMP3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr19:48,325,552...48,330,553
Ensembl chr19:48,321,509...48,330,553
|
|
G |
EPAS1 |
endothelial PAS domain protein 1 |
increases stability |
ISO |
Dactinomycin results in increased stability of EPAS1 protein |
CTD |
PMID:23545307 |
|
NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions decreases expression |
EXP |
Dactinomycin inhibits the reaction [indoleacetic acid results in increased expression of F3 mRNA] Dactinomycin results in decreased expression of F3 mRNA |
CTD |
PMID:30324315 |
|
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
|
|
G |
FADD |
Fas associated via death domain |
decreases expression |
EXP |
Dactinomycin results in decreased expression of FADD mRNA |
CTD |
PMID:16001973 |
|
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
|
|
G |
FADS3 |
fatty acid desaturase 3 |
increases expression |
EXP |
Dactinomycin results in increased expression of FADS3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr11:61,873,526...61,892,224
Ensembl chr11:61,873,519...61,892,051
|
|
G |
FBL |
fibrillarin |
affects localization |
EXP |
Dactinomycin analog affects the localization of FBL protein |
CTD |
PMID:10942594 |
|
NCBI chr19:39,834,458...39,846,379
Ensembl chr19:39,834,458...39,846,379
|
|
G |
FCAR |
Fc alpha receptor |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of FCAR mRNA] |
CTD |
PMID:21911031 |
|
NCBI chr19:54,874,235...54,891,420
Ensembl chr19:54,874,235...54,891,420
|
|
G |
FGF2 |
fibroblast growth factor 2 |
multiple interactions decreases expression |
EXP ISO |
Dactinomycin inhibits the reaction [Sodium Chloride results in increased expression of FGF2 mRNA] Dactinomycin inhibits the reaction [FGF2 protein results in increased expression of SNCA protein] Dactinomycin results in decreased expression of FGF2 mRNA |
CTD |
PMID:12562524 PMID:26800359 |
|
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
|
|
G |
FGFR1 |
fibroblast growth factor receptor 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Triiodothyronine results in increased expression of FGFR1 mRNA] |
CTD |
PMID:12805413 |
|
NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
|
|
G |
FHL1 |
four and a half LIM domains 1 |
multiple interactions |
ISO |
Dactinomycin promotes the reaction [25-hydroxycholesterol results in increased expression of FHL1 mRNA] |
CTD |
PMID:17161435 |
|
NCBI chr X:136,146,702...136,211,359
Ensembl chr X:136,146,702...136,211,359
|
|
G |
FLNC |
filamin C |
increases expression |
EXP |
Dactinomycin results in increased expression of FLNC mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 7:128,830,406...128,859,272
Ensembl chr 7:128,830,406...128,859,274
|
|
G |
FN1 |
fibronectin 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [TGFB2 protein results in increased expression of FN1 mRNA] |
CTD |
PMID:18253093 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases expression |
ISO EXP |
Dactinomycin inhibits the reaction [beryllium sulfate results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA] Dactinomycin inhibits the reaction [Hemin results in increased expression of FOS mRNA] Dactinomycin results in decreased expression of FOS mRNA Dactinomycin inhibits the reaction [[Cycloheximide co-treated with Cadmium] results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [[EGF protein co-treated with Estradiol] results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [Fructose results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [Glucose results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [IL1A protein results in increased expression of FOS mRNA] |
CTD |
PMID:1696944 PMID:7564102 PMID:10381381 PMID:11123204 PMID:11353138 PMID:11568973 PMID:12632255 More...
|
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
FOSL1 |
FOS like 1, AP-1 transcription factor subunit |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of FOSL1 mRNA]; Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of FOSL1 mRNA] Dactinomycin results in decreased expression of FOSL1 mRNA |
CTD |
PMID:14565943 |
|
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Isoproterenol results in increased activity of G6PD protein] |
CTD |
PMID:1978808 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
multiple interactions increases expression |
EXP |
Dactinomycin inhibits the reaction [arsenite results in increased expression of GADD45A mRNA] Dactinomycin results in increased expression of GADD45A mRNA |
CTD |
PMID:17616671 PMID:21527772 |
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GALM |
galactose mutarotase |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of GALM mRNA] |
CTD |
PMID:18052213 |
|
NCBI chr 2:38,666,114...38,734,765
Ensembl chr 2:38,666,081...38,741,237
|
|
G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
increases expression |
EXP |
Dactinomycin results in increased expression of GAPDH mRNA |
CTD |
PMID:16001973 |
|
NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
|
|
G |
GAS6 |
growth arrest specific 6 |
multiple interactions increases degradation |
EXP |
Phosphates promotes the reaction [Dactinomycin results in increased degradation of GAS6 mRNA] |
CTD |
PMID:20048160 |
|
NCBI chr13:113,820,549...113,864,076
Ensembl chr13:113,820,549...113,864,076
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [Vitamin K 3 results in increased expression of GCLC mRNA] Dactinomycin inhibits the reaction [notoginsenoside R1 results in increased expression of GCLC protein] |
CTD |
PMID:11972604 PMID:24437944 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GDF15 |
growth differentiation factor 15 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [resveratrol results in increased expression of GDF15 mRNA] |
CTD |
PMID:17257620 |
|
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
|
|
G |
GDNF |
glial cell derived neurotrophic factor |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 analog results in increased expression of GDNF mRNA]; Dactinomycin inhibits the reaction [NEPP11 compound results in increased expression of GDNF mRNA] Dactinomycin results in decreased expression of GDNF mRNA |
CTD |
PMID:22982731 |
|
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
|
|
G |
GFER |
growth factor, augmenter of liver regeneration |
increases secretion multiple interactions |
ISO |
Dactinomycin results in increased secretion of GFER protein Dactinomycin promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of GFER protein]; lipopolysaccharide, Escherichia coli O111 B4 promotes the reaction [Dactinomycin results in increased secretion of GFER protein] |
CTD |
PMID:23073658 |
|
NCBI chr16:1,984,193...1,987,749
Ensembl chr16:1,984,193...1,987,749
|
|
G |
GJA1 |
gap junction protein alpha 1 |
multiple interactions |
ISO |
Dactinomycin promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA] |
CTD |
PMID:36863560 |
|
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
|
|
G |
GPR137B |
G protein-coupled receptor 137B |
increases expression |
EXP |
Dactinomycin results in increased expression of GPR137B mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:236,142,539...236,208,907
Ensembl chr 1:236,142,505...236,221,865
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein] |
CTD |
PMID:29479035 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GRM5 |
glutamate metabotropic receptor 5 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dextroamphetamine results in increased expression of GRM5 mRNA]; Dactinomycin inhibits the reaction [Dextroamphetamine results in increased expression of GRM5 protein] |
CTD |
PMID:11665859 |
|
NCBI chr11:88,504,642...89,065,982
Ensembl chr11:88,504,576...89,065,982
|
|
G |
GSTA1 |
glutathione S-transferase alpha 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of GSTA1 mRNA] |
CTD |
PMID:28483492 |
|
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
|
|
G |
GSTA5 |
glutathione S-transferase alpha 5 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Lead results in increased expression of GSTA1 mRNA]; Dactinomycin inhibits the reaction [Mercury results in increased expression of GSTA1 mRNA]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTA1 mRNA] |
CTD |
PMID:16243960 |
|
NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
decreases response to substance |
ISO |
GSTP1 protein results in decreased susceptibility to Dactinomycin |
CTD |
PMID:11455017 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
H2AX |
H2A.X variant histone |
increases expression |
EXP |
Dactinomycin results in increased expression of H2AX protein |
CTD |
PMID:31226288 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
HBEGF |
heparin binding EGF like growth factor |
multiple interactions decreases expression |
EXP |
Dactinomycin inhibits the reaction [Sodium Chloride results in increased expression of HBEGF mRNA] Dactinomycin results in decreased expression of HBEGF mRNA |
CTD |
PMID:26800359 |
|
NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
|
|
G |
HGF |
hepatocyte growth factor |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Berberine results in increased expression of HGF protein] |
CTD |
PMID:29408570 |
|
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of HIF1A protein] |
CTD |
PMID:12479793 PMID:19958256 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions decreases expression |
EXP ISO |
Dactinomycin inhibits the reaction [Ammonium Chloride results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Curcumin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [ginsenoside Rb1 results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [ginsenoside Rb1 results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Lipid Peroxides results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Nitroprusside results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Oxygen results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Plant Extracts results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Potassium Dichromate results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Resveratrol results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased expression of HMOX1 protein]; Dactinomycin results in decreased susceptibility to [surfactin peptide results in increased expression of HMOX1 mRNA]; HMOX1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; NFKBIA protein inhibits the reaction [HMOX1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]] Dactinomycin results in decreased expression of HMOX1 protein Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [cobaltous chloride results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Diclofenac results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [notoginsenoside R1 results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [resveratrol results in increased expression of HMOX1 mRNA] Dactinomycin inhibits the reaction [fisetin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [puerarin results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [puerarin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Triterpenes analog results in increased expression of HMOX1 protein] |
CTD |
PMID:8764571 PMID:9747510 PMID:9808084 PMID:11880364 PMID:12763371 PMID:15118350 PMID:15582353 PMID:15588712 PMID:15876423 PMID:15965080 PMID:16647178 PMID:17002867 PMID:18332044 PMID:18357586 PMID:19781563 PMID:20060010 PMID:20833156 PMID:21840424 PMID:24437944 PMID:25239868 PMID:26283888 PMID:26385185 PMID:26968795 PMID:27867098 PMID:30076913 More...
|
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNRNPA1 |
heterogeneous nuclear ribonucleoprotein A1 |
affects localization multiple interactions |
ISO |
Dactinomycin affects the localization of HNRNPA1 protein Dactinomycin affects the reaction [HNRNPA1 protein binds to CYP2A5 mRNA] |
CTD |
PMID:12754101 |
|
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
|
|
G |
HOMER3 |
homer scaffold protein 3 |
increases expression |
EXP |
Dactinomycin results in increased expression of HOMER3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr19:18,929,201...18,941,217
Ensembl chr19:18,929,201...18,941,261
|
|
G |
HRAS |
HRas proto-oncogene, GTPase |
multiple interactions |
EXP |
Dactinomycin promotes the reaction [[Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene] |
CTD |
PMID:9345283 |
|
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
|
|
G |
HSD11B2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Bexarotene results in increased expression of HSD11B2 mRNA]; Dactinomycin inhibits the reaction [tributyltin results in increased expression of HSD11B2 mRNA]; Dactinomycin inhibits the reaction [triphenyltin chloride results in increased expression of HSD11B2 mRNA] |
CTD |
PMID:31927052 |
|
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
|
|
G |
HSF1 |
heat shock transcription factor 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of HSF1 mRNA]; Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of HSF1 protein] |
CTD |
PMID:30309986 |
|
NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720
|
|
G |
HSP90B1 |
heat shock protein 90 beta family member 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Dithiothreitol results in increased expression of HSP90B1 mRNA] |
CTD |
PMID:34244458 |
|
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions decreases expression |
ISO EXP |
Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of HSPA5 mRNA]; Dactinomycin inhibits the reaction [lead acetate results in increased expression of HSPA5 mRNA]; Dactinomycin inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 mRNA]; Dactinomycin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA]; Dactinomycin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] [Arsenic Trioxide co-treated with Dactinomycin] results in decreased expression of HSPA5 mRNA; [Arsenic Trioxide co-treated with Dactinomycin] results in increased expression of HSPA5 protein Dactinomycin results in decreased expression of HSPA5 mRNA |
CTD |
PMID:17915553 PMID:34560123 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HTR3A |
5-hydroxytryptamine receptor 3A |
multiple interactions |
ISO |
Dactinomycin promotes the reaction [Dronabinol results in decreased activity of HTR3A protein] |
CTD |
PMID:20800662 |
|
NCBI chr11:113,975,108...113,990,313
Ensembl chr11:113,975,075...113,990,313
|
|
G |
ID1 |
inhibitor of DNA binding 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of ID1 mRNA] |
CTD |
PMID:16494909 |
|
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
|
|
G |
IER3 |
immediate early response 3 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [afimoxifene results in increased expression of IER3 mRNA] |
CTD |
PMID:16849584 |
|
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
|
|
G |
IER5 |
immediate early response 5 |
increases expression |
EXP |
Dactinomycin results in increased expression of IER5 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:181,088,700...181,092,900
Ensembl chr 1:181,088,700...181,092,900
|
|
G |
IFNA1 |
interferon alpha 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [IFNA1 protein results in increased expression of TYMP mRNA] |
CTD |
PMID:15937643 |
|
NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316
|
|
G |
IFNB1 |
interferon beta 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [IFNB1 protein results in increased expression of TYMP mRNA] |
CTD |
PMID:15937643 |
|
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
EXP |
[Dactinomycin co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA; Dactinomycin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of RNF213 mRNA]; Dactinomycin inhibits the reaction [IFNG protein results in increased expression of TYMP mRNA]; Dactinomycin inhibits the reaction [Tretinoin promotes the reaction [IFNG protein results in increased expression of IRF1 protein]] |
CTD |
PMID:15937643 PMID:16085646 PMID:26278786 PMID:29594315 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IGF1 |
insulin like growth factor 1 |
decreases response to substance |
ISO |
IGF1 protein results in decreased susceptibility to Dactinomycin |
CTD |
PMID:9525472 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Zymosan results in increased expression of IL10 mRNA] |
CTD |
PMID:17458858 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL11 |
interleukin 11 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Formaldehyde results in increased expression of IL11 mRNA] |
CTD |
PMID:22138297 |
|
NCBI chr19:55,364,382...55,370,463
Ensembl chr19:55,364,382...55,370,463
|
|
G |
IL17A |
interleukin 17A |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Glucose results in increased secretion of IL17A protein] |
CTD |
PMID:18310510 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [IL1A protein results in increased expression of FOS mRNA] |
CTD |
PMID:7564102 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [IL1B protein results in increased abundance of Dinoprostone]; Dactinomycin inhibits the reaction [IL1B protein results in increased expression of PAPPA mRNA]; Dactinomycin inhibits the reaction [IL1B protein results in increased expression of TGFB1 mRNA]; Dactinomycin inhibits the reaction [IL1B protein results in increased secretion of TGFB1 protein]; Dactinomycin inhibits the reaction [IL1B results in increased abundance of Dinoprostone]; Dactinomycin inhibits the reaction [IL1B results in increased abundance of Nitric Oxide]; Dactinomycin inhibits the reaction [IL1B results in increased expression of BCL2 protein]; Dactinomycin inhibits the reaction [IL1B results in increased expression of MCL1 protein]; Dactinomycin inhibits the reaction [IL1B results in increased secretion of CSF2 protein] Dactinomycin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; Dactinomycin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] Dactinomycin inhibits the reaction [IL1B protein results in decreased expression of THRA mRNA alternative form]; Dactinomycin inhibits the reaction [IL1B protein results in decreased expression of THRA mRNA] |
CTD |
PMID:9606035 PMID:11286988 PMID:12512699 PMID:16338976 PMID:16365456 PMID:16492401 PMID:17641275 More...
|
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL2 |
interleukin 2 |
multiple interactions |
EXP |
[Dactinomycin co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL27RA |
interleukin 27 receptor subunit alpha |
increases expression |
EXP |
Dactinomycin results in increased expression of IL27RA mRNA |
CTD |
PMID:21527772 |
|
NCBI chr19:14,031,762...14,053,218
Ensembl chr19:14,031,762...14,053,218
|
|
G |
IL6 |
interleukin 6 |
decreases secretion |
EXP |
Dactinomycin results in decreased secretion of IL6 protein |
CTD |
PMID:11216681 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS |
insulin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [[[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] co-treated with alitretinoin] results in increased expression of SLC27A1 mRNA] |
CTD |
PMID:10777552 |
|
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [bisphenol A results in increased secretion of INS1 protein]; Dactinomycin inhibits the reaction [nonylphenol results in increased secretion of INS1 protein] |
CTD |
PMID:15778011 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
IRF1 |
interferon regulatory factor 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Tretinoin promotes the reaction [IFNG protein results in increased expression of IRF1 protein]]; Dactinomycin inhibits the reaction [Tretinoin results in increased expression of IRF1 mRNA] |
CTD |
PMID:16085646 PMID:16636311 |
|
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
|
|
G |
ITGA2B |
integrin subunit alpha 2b |
increases expression |
EXP |
Dactinomycin results in increased expression of ITGA2B mRNA |
CTD |
PMID:21527772 |
|
NCBI chr17:44,372,181...44,389,649
Ensembl chr17:44,372,180...44,389,649
|
|
G |
ITPR1 |
inositol 1,4,5-trisphosphate receptor type 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Ethanol results in increased expression of ITPR1 mRNA]; Dactinomycin inhibits the reaction [linsidomine results in increased expression of ITPR1 mRNA] |
CTD |
PMID:17241155 |
|
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
|
|
G |
JAK2 |
Janus kinase 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Aldosterone results in increased phosphorylation of JAK2 protein] |
CTD |
PMID:15932931 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [beryllium sulfate results in increased expression of JUN mRNA]; Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of JUN mRNA] Dactinomycin results in decreased expression of JUN mRNA Dactinomycin inhibits the reaction [Cadmium results in increased expression of JUN mRNA]; Dactinomycin inhibits the reaction [Fructose results in increased expression of JUN mRNA]; Dactinomycin inhibits the reaction [Glucose results in increased expression of JUN mRNA] |
CTD |
PMID:1696944 PMID:11123204 PMID:11353138 PMID:11568973 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
KIF1A |
kinesin family member 1A |
increases expression |
EXP |
Dactinomycin results in increased expression of KIF1A mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 2:240,713,767...240,821,403
Ensembl chr 2:240,713,761...240,824,293
|
|
G |
KRAS |
KRAS proto-oncogene, GTPase |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] which results in increased expression of TNFRSF10B mRNA] |
CTD |
PMID:27222248 |
|
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
|
|
G |
KRT80 |
keratin 80 |
increases expression |
EXP |
Dactinomycin results in increased expression of KRT80 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr12:52,168,996...52,192,014
Ensembl chr12:52,168,996...52,192,014
|
|
G |
LAMC2 |
laminin subunit gamma 2 |
increases expression |
EXP |
Dactinomycin results in increased expression of LAMC2 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:183,186,264...183,258,968
Ensembl chr 1:183,186,238...183,245,127
|
|
G |
LDLR |
low density lipoprotein receptor |
decreases expression multiple interactions |
EXP |
Dactinomycin results in decreased expression of LDLR mRNA Ascorbic Acid inhibits the reaction [Dactinomycin results in decreased expression of LDLR mRNA] |
CTD |
PMID:32913121 |
|
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
|
|
G |
LEP |
leptin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [LEP protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:12704794 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
LGALS3 |
galectin 3 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] |
CTD |
PMID:21821001 |
|
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
|
|
G |
LGALS7 |
galectin 7 |
increases expression |
EXP |
Dactinomycin results in increased expression of LGALS7 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr19:38,770,968...38,773,517
Ensembl chr19:38,789,200...38,791,754 Ensembl chr19:38,789,200...38,791,754
|
|
G |
LMNB1 |
lamin B1 |
decreases expression |
EXP |
Dactinomycin results in decreased expression of LMNB1 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020
|
|
G |
MAP1LC3B |
microtubule associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Ethanol results in increased expression of MAP1LC3B protein] |
CTD |
PMID:24095927 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
|
|
G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
decreases expression |
EXP |
Dactinomycin results in decreased expression of MAP2K4 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
|
|
G |
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7 |
decreases expression |
EXP |
Dactinomycin results in decreased expression of MAP3K7 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases expression |
EXP ISO |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] Dactinomycin results in increased expression of MAPK1 protein |
CTD |
PMID:14640974 PMID:15959627 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases expression |
EXP ISO |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein] Dactinomycin results in increased expression of MAPK3 protein PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:14640974 PMID:15959627 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression multiple interactions |
EXP |
Dactinomycin results in decreased expression of MCL1 mRNA Dactinomycin inhibits the reaction [IL1B results in increased expression of MCL1 protein]; Dactinomycin inhibits the reaction [TNF results in increased expression of MCL1 protein]; Quercetin promotes the reaction [Dactinomycin results in decreased expression of MCL1 mRNA] |
CTD |
PMID:16492401 PMID:21750559 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
MIR21 |
microRNA 21 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Dehydroepiandrosterone results in increased expression of MIR21 mRNA]; Dactinomycin inhibits the reaction [Dihydrotestosterone results in increased expression of MIR21 mRNA]; Dactinomycin inhibits the reaction [Estradiol results in decreased expression of MIR21 mRNA]; Dactinomycin inhibits the reaction [fludioxonil results in increased expression of MIR21 mRNA]; Dactinomycin inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of MIR21 mRNA] |
CTD |
PMID:19264808 PMID:23052036 PMID:25969534 |
|
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
|
|
G |
MIR22 |
microRNA 22 |
multiple interactions |
EXP |
[Dactinomycin co-treated with Dehydroepiandrosterone] results in increased expression of MIR22 mRNA; Dactinomycin promotes the reaction [Dehydroepiandrosterone results in increased expression of MIR22 mRNA] |
CTD |
PMID:25969534 |
|
NCBI chr17:1,713,903...1,713,987
Ensembl chr17:1,713,903...1,713,987
|
|
G |
MLLT11 |
MLLT11 transcription factor 7 cofactor |
increases expression |
EXP |
Dactinomycin results in increased expression of MLLT11 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544
|
|
G |
MMP1 |
matrix metallopeptidase 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of MMP1 protein] |
CTD |
PMID:19136476 |
|
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
EXP |
Dactinomycin inhibits the reaction [arsenic trioxide results in increased expression of MMP9 mRNA] Dactinomycin results in decreased expression of MMP9 mRNA |
CTD |
PMID:24956101 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MN1 |
MN1 proto-oncogene, transcriptional regulator |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Calcitriol results in increased expression of MN1 mRNA] |
CTD |
PMID:15890672 |
|
NCBI chr22:27,748,277...27,801,756
Ensembl chr22:27,748,277...27,801,756
|
|
G |
MRPL41 |
mitochondrial ribosomal protein L41 |
multiple interactions |
EXP |
Dactinomycin promotes the reaction [MRPL41 protein results in increased stability of and affects the localization of TP53 protein] |
CTD |
PMID:16024796 |
|
NCBI chr 9:137,551,879...137,552,555
Ensembl chr 9:137,551,879...137,552,555
|
|
G |
MT1X |
metallothionein 1X |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Buthionine Sulfoximine promotes the reaction [Paraquat results in increased expression of MT1 mRNA]]; Dactinomycin inhibits the reaction [Paraquat results in increased expression of MT1 mRNA] |
CTD |
PMID:8966720 |
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
MT2A |
metallothionein 2A |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA] |
CTD |
PMID:17234632 |
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
MTTP |
microsomal triglyceride transfer protein |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [pirinixic acid results in increased expression of MTTP mRNA] |
CTD |
PMID:15537571 |
|
NCBI chr 4:99,564,130...99,623,997
Ensembl chr 4:99,564,081...99,623,997
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
decreases expression multiple interactions |
EXP ISO |
Dactinomycin results in decreased expression of MYC mRNA Dactinomycin inhibits the reaction [Cadmium results in increased expression of MYC mRNA] Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of MYC mRNA] |
CTD |
PMID:1696944 PMID:11353138 PMID:16001973 PMID:21527772 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
MYLK |
myosin light chain kinase |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [TNF protein results in increased expression of MYLK mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of MYLK protein] |
CTD |
PMID:15701621 |
|
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
|
|
G |
NAV2 |
neuron navigator 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of NAV2 mRNA] |
CTD |
PMID:16688769 |
|
NCBI chr11:19,345,236...20,121,601
Ensembl chr11:19,350,724...20,121,601
|
|
G |
NCF1 |
neutrophil cytosolic factor 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of NCF1 mRNA] |
CTD |
PMID:19559082 |
|
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
|
|
G |
NDRG1 |
N-myc downstream regulated 1 |
multiple interactions |
ISO |
[nickel chloride co-treated with Dactinomycin] results in increased stability of NDRG1 mRNA; [Oxygen deficiency co-treated with Dactinomycin] results in increased stability of NDRG1 mRNA |
CTD |
PMID:10646848 |
|
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
|
|
G |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Tretinoin results in increased expression of NEDD9 mRNA] |
CTD |
PMID:16688769 |
|
NCBI chr 6:11,183,298...11,382,348
Ensembl chr 6:11,183,298...11,382,348
|
|
G |
NETO2 |
neuropilin and tolloid like 2 |
increases expression |
EXP |
Dactinomycin results in increased expression of NETO2 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr16:47,077,703...47,143,945
Ensembl chr16:47,077,703...47,143,945
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NFE2L2 mRNA] |
CTD |
PMID:22019695 PMID:24632381 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
decreases expression multiple interactions |
EXP |
Dactinomycin results in decreased expression of NFKB1 mRNA [RELA protein co-treated with NFKB1 protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 PMID:16001973 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
EXP |
NFKBIA protein inhibits the reaction [HMOX1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]] |
CTD |
PMID:11880364 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NGF |
nerve growth factor |
multiple interactions decreases expression |
ISO |
Dactinomycin inhibits the reaction [9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 analog results in increased expression of NGF mRNA]; Dactinomycin inhibits the reaction [NEPP11 compound results in increased expression of NGF mRNA] Dactinomycin results in decreased expression of NGF mRNA |
CTD |
PMID:22982731 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Asbestos, Crocidolite results in increased expression of NLRP3 mRNA] |
CTD |
PMID:23937860 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] Dactinomycin inhibits the reaction [[Raloxifene Hydrochloride co-treated with 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid] results in increased expression of NOS2 protein] |
CTD |
PMID:11286988 PMID:28138957 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NPPC |
natriuretic peptide C |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Estradiol results in increased expression of NPPC mRNA] |
CTD |
PMID:9435603 |
|
NCBI chr 2:231,921,809...231,926,396
Ensembl chr 2:231,921,809...231,926,396
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Biological Products results in increased expression of NQO1 mRNA]; Dactinomycin inhibits the reaction [Itraconazole results in increased expression of NQO1 mRNA]; Dactinomycin inhibits the reaction [Ketoconazole results in increased expression of NQO1 mRNA]; Dactinomycin inhibits the reaction [Lead results in increased expression of NQO1 mRNA]; Dactinomycin inhibits the reaction [Mercury results in increased expression of NQO1 mRNA]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; Dactinomycin promotes the reaction [Chromium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] Dactinomycin inhibits the reaction [notoginsenoside R1 results in increased expression of NQO1 protein] |
CTD |
PMID:16243960 PMID:17923278 PMID:18474416 PMID:22570534 PMID:24437944 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR0B1 |
nuclear receptor subfamily 0 group B member 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Bucladesine results in decreased expression of NR0B1 mRNA]; Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of NR0B1 mRNA] |
CTD |
PMID:18787026 |
|
NCBI chr X:30,304,206...30,309,390
Ensembl chr X:30,304,206...30,309,390
|
|
G |
NR0B2 |
nuclear receptor subfamily 0 group B member 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Fenofibrate results in increased expression of NR0B2 mRNA] |
CTD |
PMID:19593819 |
|
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [Clofibrate results in increased expression of NR1I2 protein]; Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of NR1I2 mRNA]; Dactinomycin inhibits the reaction [perfluorodecanoic acid results in increased expression of NR1I2 protein] Dactinomycin inhibits the reaction [ochratoxin A results in decreased expression of NR1I2 mRNA] |
CTD |
PMID:15826607 PMID:20599767 PMID:26341324 |
|
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Dexamethasone affects the localization of NR3C1 protein]; Dactinomycin inhibits the reaction [Dexamethasone binds to NR3C1 protein]; Dactinomycin inhibits the reaction [Dexamethasone results in increased degradation of NR3C1 protein] |
CTD |
PMID:21569845 |
|
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
|
|
G |
NTHL1 |
nth like DNA glycosylase 1 |
decreases expression |
EXP |
Dactinomycin results in decreased expression of NTHL1 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr16:2,039,820...2,047,834
Ensembl chr16:2,039,815...2,047,866
|
|
G |
OPA1 |
OPA1 mitochondrial dynamin like GTPase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [15-deoxyprostaglandin J2 results in increased expression of OPA1 protein alternative form] |
CTD |
PMID:20678484 |
|
NCBI chr 3:193,593,208...193,697,811
Ensembl chr 3:193,593,144...193,697,811
|
|
G |
PAPPA |
pappalysin 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [IL1B protein results in increased expression of PAPPA mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of PAPPA mRNA] |
CTD |
PMID:16338976 |
|
NCBI chr 9:116,153,791...116,402,321
Ensembl chr 9:116,153,791...116,402,321
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions |
EXP ISO |
[TNF co-treated with Dactinomycin] results in increased cleavage of PARP1 protein; Dactinomycin promotes the reaction [TNF results in increased cleavage of PARP1 protein]; PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] PLD2 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] |
CTD |
PMID:14640974 PMID:16492401 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCK1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Hydrocortisone results in increased activity of PCK1 protein] |
CTD |
PMID:6476976 |
|
NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121
|
|
G |
PCNA |
proliferating cell nuclear antigen |
decreases expression multiple interactions |
ISO EXP |
Dactinomycin results in decreased expression of PCNA protein Dactinomycin inhibits the reaction [Vitamin K 3 results in decreased expression of PCNA protein] |
CTD |
PMID:15959627 PMID:21533478 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PLAT |
plasminogen activator, tissue type |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Catechin results in increased expression of PLAT mRNA]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of PLAT mRNA]; Dactinomycin inhibits the reaction [Resveratrol results in increased expression of PLAT mRNA] |
CTD |
PMID:11236827 |
|
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
|
|
G |
PLAU |
plasminogen activator, urokinase |
multiple interactions increases expression |
EXP |
Dactinomycin inhibits the reaction [Catechin results in increased expression of PLAU mRNA]; Dactinomycin inhibits the reaction [Quercetin results in increased expression of PLAU mRNA]; Dactinomycin inhibits the reaction [resveratrol results in increased expression of PLAU mRNA] Dactinomycin results in increased expression of PLAU mRNA |
CTD |
PMID:11236827 PMID:21527772 |
|
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
|
|
G |
PLD1 |
phospholipase D1 |
multiple interactions |
EXP |
PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein]; PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PRKCD protein]; PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein]; PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:14640974 |
|
NCBI chr 3:171,600,404...171,810,483
Ensembl chr 3:171,600,404...171,810,950
|
|
G |
PLD2 |
phospholipase D2 |
multiple interactions |
ISO |
PLD2 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein]; PLD2 protein inhibits the reaction [Dactinomycin results in increased cleavage of PRKCD protein]; PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein]; PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:14640974 |
|
NCBI chr17:4,807,152...4,823,430
Ensembl chr17:4,807,152...4,823,434
|
|
G |
POLH |
DNA polymerase eta |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [fotemustine results in increased expression of POLH mRNA] |
CTD |
PMID:25125662 |
|
NCBI chr 6:43,576,185...43,620,523
Ensembl chr 6:43,576,185...43,620,523
|
|
G |
POLR2A |
RNA polymerase II subunit A |
decreases phosphorylation increases phosphorylation multiple interactions |
EXP |
Dactinomycin results in decreased phosphorylation of POLR2A protein Dactinomycin results in increased phosphorylation of POLR2A protein [Dactinomycin co-treated with sodium arsenite] results in increased phosphorylation of POLR2A protein |
CTD |
PMID:8126066 |
|
NCBI chr17:7,484,366...7,514,616
Ensembl chr17:7,484,366...7,514,616
|
|
G |
POMT1 |
protein O-mannosyltransferase 1 |
increases expression |
EXP |
Dactinomycin results in increased expression of POMT1 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 9:131,502,918...131,523,799
Ensembl chr 9:131,502,789...131,523,806
|
|
G |
PRDX1 |
peroxiredoxin 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [sodium arsenate results in increased expression of PRDX1 mRNA]; Dactinomycin inhibits the reaction [sodium arsenate results in increased expression of PRDX1 protein] |
CTD |
PMID:11796722 |
|
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
|
|
G |
PRDX6 |
peroxiredoxin 6 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Hydrogen Peroxide results in increased expression of PRDX6 mRNA]; Dactinomycin inhibits the reaction [Paraquat results in increased expression of PRDX6 mRNA] |
CTD |
PMID:12851211 |
|
NCBI chr 1:173,477,335...173,488,815
Ensembl chr 1:173,477,330...173,488,815
|
|
G |
PRKCD |
protein kinase C delta |
multiple interactions |
EXP ISO |
PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PRKCD protein] PLD2 protein inhibits the reaction [Dactinomycin results in increased cleavage of PRKCD protein] |
CTD |
PMID:14640974 |
|
NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
|
|
G |
PRL |
prolactin |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [PRL protein results in increased expression of SLC30A2 mRNA] |
CTD |
PMID:19494234 |
|
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
|
|
G |
PROCR |
protein C receptor |
increases expression |
EXP |
Dactinomycin results in increased expression of PROCR mRNA |
CTD |
PMID:21527772 |
|
NCBI chr20:35,171,096...35,216,259
Ensembl chr20:35,172,072...35,216,240
|
|
G |
PROM1 |
prominin 1 |
multiple interactions decreases expression |
EXP |
Dactinomycin results in decreased expression of and affects the localization of PROM1 protein Dactinomycin results in decreased expression of PROM1 mRNA |
CTD |
PMID:31226288 |
|
NCBI chr 4:15,968,228...16,084,023
Ensembl chr 4:15,963,076...16,084,378
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases degradation decreases expression |
EXP ISO |
Dactinomycin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Sodium Fluoride results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein]; Dactinomycin inhibits the reaction [Zinc results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Zinc results in increased expression of PTGS2 protein] Dactinomycin results in increased degradation of PTGS2 mRNA CDKN1B protein affects the reaction [Dactinomycin results in increased degradation of PTGS2 mRNA]; Dactinomycin inhibits the reaction [nickel chloride results in increased expression of PTGS2 protein]; Dactinomycin inhibits the reaction [nickel sulfide results in increased expression of PTGS2 protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] Dactinomycin results in decreased expression of PTGS2 mRNA Dactinomycin inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; Dactinomycin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] |
CTD |
PMID:9576062 PMID:11286988 PMID:16894348 PMID:17065197 PMID:18513776 PMID:18650268 PMID:19376214 PMID:23639288 PMID:24967690 More...
|
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTK2 |
protein tyrosine kinase 2 |
decreases expression |
ISO |
Dactinomycin results in decreased expression of PTK2 protein |
CTD |
PMID:15959627 |
|
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
|
|
G |
RAD51 |
RAD51 recombinase |
decreases expression multiple interactions |
EXP |
Dactinomycin results in decreased expression of RAD51 mRNA tetrachlorobenzoquinone promotes the reaction [Dactinomycin results in decreased expression of RAD51 mRNA] |
CTD |
PMID:27989139 |
|
NCBI chr15:40,694,733...40,732,340
Ensembl chr15:40,694,774...40,732,340
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
Dactinomycin results in decreased expression of RAF1 protein |
CTD |
PMID:15959627 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201
|
|
G |
REL |
REL proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
[RELA protein co-treated with REL protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr 2:60,881,574...60,931,612
Ensembl chr 2:60,881,491...60,931,612
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
[RELA protein co-treated with NFKB1 protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; [RELA protein co-treated with REL protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; RELA protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
REN |
renin |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Dobutamine results in increased secretion of REN protein]; Dactinomycin inhibits the reaction [Terbutaline results in increased secretion of REN protein] |
CTD |
PMID:9203624 |
|
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
|
|
G |
RETSAT |
retinol saturase |
increases expression |
EXP |
Dactinomycin results in increased expression of RETSAT mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 2:85,341,955...85,354,528
Ensembl chr 2:85,341,955...85,354,531
|
|
G |
RHOB |
ras homolog family member B |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [cytotoxic necrotizing factor type 1 results in increased expression of RHOB mRNA]; Dactinomycin inhibits the reaction [cytotoxic necrotizing factor type 1 results in increased expression of RHOB protein] |
CTD |
PMID:23732113 |
|
NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440
|
|
G |
RIPPLY3 |
ripply transcriptional repressor 3 |
increases expression |
EXP |
Dactinomycin results in increased expression of RIPPLY3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr21:37,006,150...37,019,662
Ensembl chr21:37,006,150...37,019,662
|
|
G |
RNF213 |
ring finger protein 213 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of RNF213 mRNA] |
CTD |
PMID:26278786 |
|
NCBI chr17:80,260,852...80,398,794
Ensembl chr17:80,260,852...80,398,794
|
|
G |
RNY1 |
RNA, Ro60-associated Y1 |
increases degradation |
EXP |
Dactinomycin results in increased degradation of RNY1 mRNA |
CTD |
PMID:10455152 |
|
NCBI chr 7:148,987,136...148,987,248
Ensembl chr 7:148,987,136...148,987,248
|
|
G |
RNY3 |
RNA, Ro60-associated Y3 |
increases degradation |
EXP |
Dactinomycin results in increased degradation of RNY3 mRNA |
CTD |
PMID:10455152 |
|
NCBI chr 7:148,983,755...148,983,856
Ensembl chr 7:148,983,755...148,983,856
|
|
G |
RNY4 |
RNA, Ro60-associated Y4 |
increases degradation |
EXP |
Dactinomycin results in increased degradation of RNY4 mRNA |
CTD |
PMID:10455152 |
|
NCBI chr 7:148,963,315...148,963,410
Ensembl chr 7:148,963,315...148,963,410
|
|
G |
RNY5 |
RNA, Ro60-associated Y5 |
increases degradation |
EXP |
Dactinomycin results in increased degradation of RNY5 mRNA |
CTD |
PMID:10455152 |
|
NCBI chr 7:148,941,488...148,941,571
|
|
G |
ROS1 |
ROS proto-oncogene 1, receptor tyrosine kinase |
increases expression |
EXP |
Dactinomycin results in increased expression of ROS1 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 6:117,287,353...117,425,942
Ensembl chr 6:117,287,353...117,425,942
|
|
G |
RPL34 |
ribosomal protein L34 |
increases expression |
EXP |
Dactinomycin results in increased expression of RPL34 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 4:108,620,576...108,630,484
Ensembl chr 4:108,620,569...108,630,412
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
EXP ISO |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:14640974 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
RRAS |
RAS related |
increases expression |
EXP |
Dactinomycin results in increased expression of RRAS mRNA |
CTD |
PMID:21527772 |
|
NCBI chr19:49,635,292...49,640,143
Ensembl chr19:49,635,292...49,640,143
|
|
G |
SAT1 |
spermidine/spermine N1-acetyltransferase 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [N(1),N(11)-diethylnorspermine results in increased expression of SAT1 mRNA] |
CTD |
PMID:16637064 |
|
NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210
|
|
G |
SCD |
stearoyl-CoA desaturase |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [ciprofibrate results in increased expression of SCD1 mRNA] |
CTD |
PMID:11172741 |
|
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
|
|
G |
SCNN1B |
sodium channel epithelial 1 subunit beta |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of SCNN1B mRNA] |
CTD |
PMID:10942727 |
|
NCBI chr16:23,278,231...23,381,294
Ensembl chr16:23,278,231...23,381,294
|
|
G |
SCNN1G |
sodium channel epithelial 1 subunit gamma |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of SCNN1G mRNA] |
CTD |
PMID:10942727 |
|
NCBI chr16:23,182,745...23,216,883
Ensembl chr16:23,182,745...23,216,883
|
|
G |
SDC3 |
syndecan 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Estradiol results in increased expression of SDC3 mRNA] |
CTD |
PMID:11024013 |
|
NCBI chr 1:30,869,466...30,909,735
Ensembl chr 1:30,869,466...30,908,758
|
|
G |
SESN2 |
sestrin 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [erastin results in increased expression of SESN2 mRNA] |
CTD |
PMID:31323261 |
|
NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
|
|
G |
SFN |
stratifin |
increases expression |
EXP |
Dactinomycin results in increased expression of SFN mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456
|
|
G |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of SGK1 mRNA]; Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of SGK1 protein] |
CTD |
PMID:25128767 |
|
NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112
|
|
G |
SHH |
sonic hedgehog signaling molecule |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [SHH protein alternative form results in increased expression of ABCG2 protein] |
CTD |
PMID:21625222 |
|
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
|
|
G |
SIRT1 |
sirtuin 1 |
multiple interactions |
EXP ISO |
Dactinomycin affects the reaction [antimony trichloride results in decreased expression of SIRT1 mRNA] TAF15 mRNA inhibits the reaction [Dactinomycin results in decreased expression of SIRT1 mRNA] |
CTD |
PMID:30055241 PMID:35307376 |
|
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
|
|
G |
SLC25A14 |
solute carrier family 25 member 14 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SLC25A14 mRNA]; Dactinomycin inhibits the reaction [Dopamine results in increased expression of SLC25A14 mRNA] |
CTD |
PMID:20600837 |
|
NCBI chr X:130,339,919...130,373,357
Ensembl chr X:130,339,888...130,373,361
|
|
G |
SLC27A1 |
solute carrier family 27 member 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [[[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] co-treated with alitretinoin] results in increased expression of SLC27A1 mRNA] Dactinomycin inhibits the reaction [alitretinoin results in increased expression of SLC27A1 mRNA] |
CTD |
PMID:10777552 |
|
NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168
|
|
G |
SLC2A2 |
solute carrier family 2 member 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Fructose results in increased expression of SLC2A2 mRNA]; Dactinomycin inhibits the reaction [Glucose results in increased expression of SLC2A2 mRNA] |
CTD |
PMID:12787936 |
|
NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743
|
|
G |
SLC2A5 |
solute carrier family 2 member 5 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Fructose promotes the reaction [SLC2A5 protein results in increased uptake of Fructose]]; Dactinomycin inhibits the reaction [Fructose results in increased expression of SLC2A5 mRNA] |
CTD |
PMID:11123204 |
|
NCBI chr 1:9,035,106...9,094,195
Ensembl chr 1:9,035,106...9,088,478
|
|
G |
SLC30A2 |
solute carrier family 30 member 2 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [PRL protein results in increased expression of SLC30A2 mRNA] |
CTD |
PMID:19494234 |
|
NCBI chr 1:26,037,252...26,046,118
Ensembl chr 1:26,037,252...26,046,118
|
|
G |
SLC30A5 |
solute carrier family 30 member 5 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [zinc chloride results in decreased expression of SLC30A5 mRNA] |
CTD |
PMID:17234632 |
|
NCBI chr 5:69,094,014...69,131,069
Ensembl chr 5:69,093,991...69,131,069
|
|
G |
SLC39A10 |
solute carrier family 39 member 10 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 mRNA] |
CTD |
PMID:21738690 |
|
NCBI chr 2:195,613,029...195,737,700
Ensembl chr 2:195,575,977...195,737,702
|
|
G |
SLC39A4 |
solute carrier family 39 member 4 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Zinc deficiency results in increased expression of SLC39A4 mRNA]; Dactinomycin inhibits the reaction [Zinc results in decreased expression of SLC39A4 mRNA] |
CTD |
PMID:18020946 |
|
NCBI chr 8:144,412,414...144,416,844
Ensembl chr 8:144,409,742...144,416,844
|
|
G |
SLC3A2 |
solute carrier family 3 member 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of SLC3A2 mRNA] |
CTD |
PMID:26621329 |
|
NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
|
|
G |
SLC40A1 |
solute carrier family 40 member 1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Cadmium results in increased expression of SLC40A1 mRNA] |
CTD |
PMID:20090884 |
|
NCBI chr 2:189,560,590...189,580,786
Ensembl chr 2:189,560,590...189,583,758
|
|
G |
SLC7A11 |
solute carrier family 7 member 11 |
decreases expression |
EXP |
Dactinomycin results in decreased expression of SLC7A11 protein |
CTD |
PMID:31226288 |
|
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
|
|
G |
SLC7A5 |
solute carrier family 7 member 5 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of SLC7A5 mRNA] |
CTD |
PMID:26621329 |
|
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
|
|
G |
SMPD1 |
sphingomyelin phosphodiesterase 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [diethyl maleate results in increased expression of SMPD1 mRNA] |
CTD |
PMID:25762726 |
|
NCBI chr11:6,390,474...6,394,996
Ensembl chr11:6,390,440...6,394,998
|
|
G |
SNCA |
synuclein alpha |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [FGF2 protein results in increased expression of SNCA protein] |
CTD |
PMID:12562524 |
|
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
|
|
G |
SOCS3 |
suppressor of cytokine signaling 3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Cycloheximide results in increased expression of SOCS3 mRNA] |
CTD |
PMID:23237828 |
|
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [Paclitaxel results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [SOD2 protein results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [Vinblastine results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [Vincristine results in increased expression of SOD2 mRNA]; SOD2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] Dactinomycin inhibits the reaction [polysaccharide-K results in increased expression of SOD2] Dactinomycin inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA] |
CTD |
PMID:9852137 PMID:11154046 PMID:11880364 PMID:12031898 PMID:14996425 PMID:15683720 More...
|
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
decreases expression |
EXP |
Dactinomycin results in decreased expression of SOS1 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 2:38,981,549...39,124,868
Ensembl chr 2:38,962,206...39,124,345
|
|
G |
SOX17 |
SRY-box transcription factor 17 |
decreases localization |
EXP |
Dactinomycin results in decreased localization of SOX17 protein |
CTD |
PMID:24154490 |
|
NCBI chr 8:54,457,935...54,460,892
Ensembl chr 8:54,457,935...54,460,892
|
|
G |
SPATA18 |
spermatogenesis associated 18 |
increases expression |
EXP |
Dactinomycin results in increased expression of SPATA18 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 4:52,051,304...52,097,299
Ensembl chr 4:52,051,304...52,097,299
|
|
G |
SQSTM1 |
sequestosome 1 |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [Ethanol results in decreased expression of SQSTM1 protein] Dactinomycin inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of SQSTM1 mRNA] |
CTD |
PMID:24095927 PMID:25301941 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
increases expression |
EXP |
Dactinomycin results in increased expression of STAT1 mRNA |
CTD |
PMID:16001973 |
|
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
|
|
G |
STMN3 |
stathmin 3 |
increases expression |
EXP |
Dactinomycin results in increased expression of STMN3 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr20:63,639,712...63,653,424
Ensembl chr20:63,639,705...63,657,682
|
|
G |
STOM |
stomatin |
increases expression |
EXP |
Dactinomycin results in increased expression of STOM mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 9:121,338,987...121,370,250
Ensembl chr 9:121,338,987...121,370,304
|
|
G |
SULT1A1 |
sulfotransferase family 1A member 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Gallic Acid results in increased expression of SULT1A1 mRNA] |
CTD |
PMID:16308312 |
|
NCBI chr16:28,605,258...28,623,375
Ensembl chr16:28,605,196...28,610,044
|
|
G |
TAF15 |
TATA-box binding protein associated factor 15 |
multiple interactions |
ISO |
TAF15 mRNA inhibits the reaction [Dactinomycin results in decreased expression of SIRT1 mRNA] |
CTD |
PMID:35307376 |
|
NCBI chr17:35,809,484...35,847,242
Ensembl chr17:35,809,482...35,864,615
|
|
G |
TAP1 |
transporter 1, ATP binding cassette subfamily B member |
increases expression |
EXP |
Dactinomycin results in increased expression of TAP1 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
|
|
G |
TAT |
tyrosine aminotransferase |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [Dexamethasone results in increased activity of TAT protein]; Dactinomycin inhibits the reaction [Dexamethasone results in increased expression of TAT mRNA]; Dactinomycin inhibits the reaction [Ursodeoxycholic Acid promotes the reaction [Dexamethasone results in increased activity of TAT protein]] |
CTD |
PMID:9398635 PMID:20599767 PMID:28483492 |
|
NCBI chr16:71,565,660...71,577,092
Ensembl chr16:71,565,660...71,577,092
|
|
G |
TBX3 |
T-box transcription factor 3 |
multiple interactions |
EXP |
actinomycin D inhibits the reaction [all-trans-retinoic acid increases expression of TBX3 mRNA in melanoma cells] |
RGD |
PMID:22535523 |
RGD:151361117 |
NCBI chr12:114,670,255...114,684,175
Ensembl chr12:114,670,255...114,684,175
|
|
G |
TCF4 |
transcription factor 4 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of TCF4 mRNA] |
CTD |
PMID:20459685 |
|
NCBI chr18:55,222,185...55,635,957
Ensembl chr18:55,222,185...55,664,787
|
|
G |
TDO2 |
tryptophan 2,3-dioxygenase |
affects activity |
ISO |
Dactinomycin affects the activity of TDO2 protein |
CTD |
PMID:7306070 |
|
NCBI chr 4:155,903,696...155,920,406
Ensembl chr 4:155,854,738...155,920,406
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [IL1B protein results in increased expression of TGFB1 mRNA]; Dactinomycin inhibits the reaction [IL1B protein results in increased secretion of TGFB1 protein]; Dactinomycin inhibits the reaction [TGFB1 protein results in decreased expression of AHR mRNA] |
CTD |
PMID:9145908 PMID:16365456 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TGFB2 |
transforming growth factor beta 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mRNA]; Dactinomycin inhibits the reaction [TGFB2 protein results in increased expression of FN1 mRNA] |
CTD |
PMID:18253093 |
|
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
|
|
G |
THRA |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [IL1B protein results in decreased expression of THRA mRNA alternative form]; Dactinomycin inhibits the reaction [IL1B protein results in decreased expression of THRA mRNA] |
CTD |
PMID:17641275 |
|
NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
|
|
G |
TIPARP |
TCDD inducible poly(ADP-ribose) polymerase |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA] |
CTD |
PMID:12147270 |
|
NCBI chr 3:156,674,590...156,706,770
Ensembl chr 3:156,673,235...156,706,770
|
|
G |
TMEFF2 |
transmembrane protein with EGF like and two follistatin like domains 2 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Dihydrotestosterone results in increased expression of TMEFF2 mRNA] |
CTD |
PMID:23405127 |
|
NCBI chr 2:191,949,046...192,194,933
Ensembl chr 2:191,949,043...192,194,933
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases response to substance |
ISO EXP |
[Dactinomycin co-treated with TNF protein] results in increased expression of BNIP3 mRNA; Dactinomycin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA]; Dactinomycin promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [lipoteichoic acid results in increased expression of TNF mRNA]] [Dactinomycin co-treated with TNF protein] results in increased activity of CASP3 protein; Dactinomycin inhibits the reaction [TNF protein results in increased expression of EDNRB mRNA] [RELA protein co-treated with NFKB1 protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; [RELA protein co-treated with REL protein] inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; [TNF co-treated with Dactinomycin] results in increased activity of CASP3 protein; [TNF co-treated with Dactinomycin] results in increased activity of CASP7 protein; [TNF co-treated with Dactinomycin] results in increased cleavage of PARP1 protein; [TNF protein co-treated with Dactinomycin] results in decreased expression of TP53 protein; [TNF protein co-treated with Dactinomycin] results in increased activity of CASP3 protein; [TNF protein co-treated with Dactinomycin] results in increased activity of CASP7 protein; BCL2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; BCL2A1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; BIRC3 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; Dactinomycin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of RNF213 mRNA]; Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL11 mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of HIF1A protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of MYLK mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of MYLK protein]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of PAPPA mRNA]; Dactinomycin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; Dactinomycin inhibits the reaction [TNF results in increased abundance of Nitric Oxide]; Dactinomycin inhibits the reaction [TNF results in increased expression of BCL2 protein]; Dactinomycin inhibits the reaction [TNF results in increased expression of MCL1 protein]; Dactinomycin inhibits the reaction [Zinc deficiency promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein]]; Dactinomycin promotes the reaction [TNF results in increased activity of CASP3 protein]; Dactinomycin promotes the reaction [TNF results in increased activity of CASP7 protein]; Dactinomycin promotes the reaction [TNF results in increased cleavage of PARP1 protein]; HMOX1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; NFKBIA protein inhibits the reaction [HMOX1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]]; RELA protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; SOD2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]; TNFAIP3 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:9576062 PMID:10100995 PMID:11592958 PMID:11880364 PMID:12479793 PMID:12812920 PMID:15531761 PMID:15701621 PMID:16338976 PMID:16492401 PMID:18845389 PMID:21496118 PMID:22207076 PMID:23300732 PMID:23968587 PMID:26278786 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFAIP3 |
TNF alpha induced protein 3 |
multiple interactions |
EXP |
TNFAIP3 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
|
|
G |
TNFRSF10A |
TNF receptor superfamily member 10a |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [tetrachlorobenzoquinone results in increased expression of TNFRSF10B mRNA] |
CTD |
PMID:27484784 |
|
NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
|
|
G |
TNFRSF10B |
TNF receptor superfamily member 10b |
decreases expression multiple interactions |
EXP |
Dactinomycin results in decreased expression of TNFRSF10B mRNA Dactinomycin inhibits the reaction [[KRAS protein mutant form affects the susceptibility to Vemurafenib] which results in increased expression of TNFRSF10B mRNA]; Dactinomycin inhibits the reaction [Celecoxib results in increased expression of TNFRSF10B mRNA]; Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of TNFRSF10B mRNA] |
CTD |
PMID:15572759 PMID:27222248 PMID:32506763 |
|
NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
multiple interactions |
EXP |
[Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP7 protein; [Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP9 protein; [Dactinomycin co-treated with TNFSF10 protein] results in increased expression of AIFM1 protein |
CTD |
PMID:17707539 |
|
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
|
|
G |
TNFSF9 |
TNF superfamily member 9 |
increases expression |
EXP |
Dactinomycin results in increased expression of TNFSF9 mRNA |
CTD |
PMID:21527772 |
|
NCBI chr19:6,531,026...6,535,924
Ensembl chr19:6,531,026...6,535,924
|
|
G |
TOP1 |
DNA topoisomerase I |
increases activity |
ISO |
Dactinomycin results in increased activity of TOP1 protein |
CTD |
PMID:2164630 |
|
NCBI chr20:41,028,822...41,124,487
Ensembl chr20:41,028,822...41,124,487
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions increases activity increases expression |
EXP |
[TNF protein co-treated with Dactinomycin] results in decreased expression of TP53 protein; Cadmium Chloride inhibits the reaction [Dactinomycin results in increased expression of and results in increased activity of TP53 protein]; Cadmium inhibits the reaction [Dactinomycin results in increased expression of and results in increased activity of TP53 protein]; Dactinomycin promotes the reaction [MRPL41 protein results in increased stability of and affects the localization of TP53 protein]; Dactinomycin results in increased expression of and affects the localization of TP53 protein; Dactinomycin results in increased expression of and results in increased activity of TP53 protein; Morphine inhibits the reaction [Dactinomycin results in increased expression of TP53 protein modified form]; Naloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in increased expression of TP53 protein modified form]] Actinomycin D inhibits the reaction [Sunitinib increases expression of TP53 mRNA and protein in breast epithelium] Dactinomycin results in increased activity of TP53 protein Dactinomycin results in increased expression of TP53 protein; Dactinomycin results in increased expression of TP53 protein modified form |
CTD RGD |
PMID:10531375 PMID:12807743 PMID:12869419 PMID:12927789 PMID:16024796 PMID:17581298 PMID:20655369 PMID:23968587 PMID:28870911 More...
|
RGD:150537096 |
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TP53I11 |
tumor protein p53 inducible protein 11 |
multiple interactions decreases expression |
EXP |
Dactinomycin inhibits the reaction [arsenic trioxide results in increased expression of TP53I11 mRNA] Dactinomycin results in decreased expression of TP53I11 mRNA |
CTD |
PMID:19333544 |
|
NCBI chr11:44,932,348...44,951,306
Ensembl chr11:44,885,903...44,951,306
|
|
G |
TRPV6 |
transient receptor potential cation channel subfamily V member 6 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [1,25-dihydroxyvitamin D results in increased expression of TRPV6 mRNA] |
CTD |
PMID:16362534 |
|
NCBI chr 7:142,871,208...142,885,745
Ensembl chr 7:142,871,208...142,885,745
|
|
G |
TUBA4A |
tubulin alpha 4a |
increases expression |
EXP |
Dactinomycin results in increased expression of TUBA4A mRNA |
CTD |
PMID:21527772 |
|
NCBI chr 2:219,249,710...219,254,740
Ensembl chr 2:219,249,710...219,277,902
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Acrolein results in increased expression of TXNRD1 mRNA]; Dactinomycin inhibits the reaction [sulforaphane results in increased expression of TXNRD1 mRNA] |
CTD |
PMID:12663510 PMID:15652504 |
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|
G |
TYMP |
thymidine phosphorylase |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [IFNA1 protein results in increased expression of TYMP mRNA]; Dactinomycin inhibits the reaction [IFNB1 protein results in increased expression of TYMP mRNA]; Dactinomycin inhibits the reaction [IFNG protein results in increased expression of TYMP mRNA]; Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]; tanespimycin inhibits the reaction [Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]] |
CTD |
PMID:15937643 PMID:30796972 |
|
NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032
|
|
G |
TYR |
tyrosinase |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [Quercetin results in increased activity of TYR protein] Dactinomycin inhibits the reaction [Phenylephrine results in increased activity of TYR protein] |
CTD |
PMID:14717847 PMID:15278367 |
|
NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759
|
|
G |
UBE2L3 |
ubiquitin conjugating enzyme E2 L3 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [beta-Naphthoflavone results in increased expression of UBE2L3 mRNA]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of UBE2L3 mRNA] |
CTD |
PMID:26318284 |
|
NCBI chr22:21,549,447...21,624,034
Ensembl chr22:21,549,447...21,624,034
|
|
G |
UCHL1 |
ubiquitin C-terminal hydrolase L1 |
multiple interactions |
ISO |
Dactinomycin inhibits the reaction [Mevinphos results in increased expression of UCHL1 protein] |
CTD |
PMID:15545831 |
|
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO EXP |
Dactinomycin inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein] Dactinomycin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA] |
CTD |
PMID:10100995 PMID:12892526 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions |
EXP ISO |
Dactinomycin inhibits the reaction [oxaliplatin results in increased expression of VEGFA mRNA]; Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of VEGFA mRNA]; Dactinomycin inhibits the reaction [Tretinoin results in increased expression of VEGFA mRNA] Dactinomycin inhibits the reaction [Cobalt results in increased expression of VEGFA mRNA]; Dactinomycin inhibits the reaction [Estradiol results in increased expression of VEGFA mRNA alternative form]; Dactinomycin inhibits the reaction [Nickel results in increased expression of VEGFA mRNA]; Dactinomycin inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA] |
CTD |
PMID:8344219 PMID:10751333 PMID:11641398 PMID:16386082 PMID:18790786 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VIM |
vimentin |
multiple interactions |
EXP |
Dactinomycin inhibits the reaction [Cadmium Chloride results in increased expression of VIM mRNA] |
CTD |
PMID:9044050 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
G |
VMP1 |
vacuole membrane protein 1 |
multiple interactions decreases expression |
EXP |
[Dactinomycin co-treated with fludioxonil] results in decreased expression of VMP1 mRNA; Dactinomycin inhibits the reaction [Dehydroepiandrosterone results in increased expression of VMP1 mRNA]; Dactinomycin inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of VMP1 mRNA] Dactinomycin results in decreased expression of VMP1 mRNA |
CTD |
PMID:23052036 PMID:25969534 |
|
NCBI chr17:59,707,654...59,842,255
Ensembl chr17:59,707,192...59,842,255
|
|
G |
XIAP |
X-linked inhibitor of apoptosis |
decreases expression |
EXP |
Dactinomycin results in decreased expression of XIAP protein |
CTD |
PMID:12430140 |
|
NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,712...123,913,972
|
|
G |
YTHDF1 |
YTH N6-methyladenosine RNA binding protein F1 |
multiple interactions |
EXP |
YTHDF1 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]; YTHDF1 protein affects the reaction [YTHDF2 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]]; YTHDF2 protein affects the reaction [YTHDF1 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]] |
CTD |
PMID:37061066 |
|
NCBI chr20:63,195,429...63,216,131
Ensembl chr20:63,195,429...63,216,139
|
|
G |
YTHDF2 |
YTH N6-methyladenosine RNA binding protein F2 |
multiple interactions |
EXP |
YTHDF1 protein affects the reaction [YTHDF2 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]]; YTHDF2 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]; YTHDF2 protein affects the reaction [YTHDF1 protein affects the reaction [Dactinomycin results in decreased stability of AKT1 mRNA]] |
CTD |
PMID:37061066 |
|
NCBI chr 1:28,736,624...28,769,775
Ensembl chr 1:28,736,621...28,769,775
|
|